reference/13345703

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/13345703

Outgoing Links

Predicate	Object
contentType	Journal Article\|Randomized Controlled Trial\|Research Support, Non-U.S. Gov't
endingPage	2264
issn	1527-3792 0022-5347
issueIdentifier	5
pageRange	2257-2264
publicationName	The Journal of urology
startingPage	2257
bibliographicCitation	Bhoopalam N, Campbell SC, Moritz T, Broderick WR, Iyer P, Arcenas AG, Van Veldhuizen PJ, Friedman N, Reda D, Warren S, Garewal H. Intravenous zoledronic acid to prevent osteoporosis in a veteran population with multiple risk factors for bone loss on androgen deprivation therapy. J Urol. 2009 Nov;182(5):2257–64. doi: 10.1016/j.juro.2009.07.046. PMID: 19758618.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_04aec2d473305f7c200cc4e1d523e7b9 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d0bab89ca41b0fdf8ed32b33293c92c4 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_9cb86330c8444ffdff3cdc0bcf2b2d92 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_922286e2016357f6b65dec1c699b0d2e http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_4b11381f96fd1abd34b4c0cff25c5566 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_2240a641eb2221e20fefdbde1575cad1 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_101a14292491ec2bd05e6cc2d766eafd http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7c183b2444f3e89d2247cdc48d68e727 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_bfa51ea5c25e7eae2c7457effd686a43 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7b1e7c8577c37fa2a81de1f6e4df8ffa http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_10f4680f3e5b30c74febfa782d66ed29
date	200911
identifier	https://doi.org/10.1016/j.juro.2009.07.046 https://pubmed.ncbi.nlm.nih.gov/19758618
isPartOf	https://portal.issn.org/resource/ISSN/1527-3792 https://portal.issn.org/resource/ISSN/0022-5347 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/5331
language	English
source	https://www.crossref.org/ https://pubmed.ncbi.nlm.nih.gov/
title	Intravenous Zoledronic Acid to Prevent Osteoporosis in a Veteran Population With Multiple Risk Factors for Bone Loss on Androgen Deprivation Therapy
discusses	http://id.nlm.nih.gov/mesh/M0001103 http://id.nlm.nih.gov/mesh/M0472480 http://id.nlm.nih.gov/mesh/M0006519 http://id.nlm.nih.gov/mesh/M0011048 http://id.nlm.nih.gov/mesh/M0234600
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D050071Q000008 http://id.nlm.nih.gov/mesh/D010024Q000517 http://id.nlm.nih.gov/mesh/D010024Q000139 http://id.nlm.nih.gov/mesh/D000726Q000009 http://id.nlm.nih.gov/mesh/D004164Q000008 http://id.nlm.nih.gov/mesh/D007093Q000008
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D008297 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D007262 http://id.nlm.nih.gov/mesh/D000368 http://id.nlm.nih.gov/mesh/D000726Q000627 http://id.nlm.nih.gov/mesh/D012307 http://id.nlm.nih.gov/mesh/D011471Q000188 http://id.nlm.nih.gov/mesh/D014728 http://id.nlm.nih.gov/mesh/D000077211
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8983 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5995 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID702 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8738 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID68740 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5460341 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID10907 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2088

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128482492 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129728658

Total number of triples: 60.